Last edition
News about "Cipla USA"
Cipla Partners with Qilu to Bring Pembrolizumab Biosimilar to US Market
Cipla and Qilu Pharmaceutical partner to commercialise QL2107, a pembrolizumab biosimilar, in the US, strengthening Cipla’s oncology and biosimilars portfolio.
Cipla USA | 04/09/2026 | By News Bureau | 100
Cipla USA Secures USFDA Approval for Generic Nintedanib to Treat Pulmonary Fibrosis
Cipla USA receives USFDA approval for generic Nintedanib capsules, expanding access to treatment for patients with idiopathic pulmonary fibrosis in the United States.
Cipla USA | 06/04/2026 | By News Bureau | 401
Cipla USA Recalls Cancer Drug Batches Over Manufacturing Issue
The recall involves Nilotinib capsules in two strengths—150 mg and 200 mg—distributed in the US market. The affected batches include a total of 435 cartons, comprising 271 cartons from one lot and 164 from another.
Cipla USA | 09/03/2026 | By Darshana | 330
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy